Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Nelotanserin for Visual Hallucinations in Lewy Body Dementia

Start: December 2015
End: November 2017
Enrollment: 20

What Is This Study About?

This Phase II study will test safety and efficacy of the experimental drug nelotanserin for the treatment of visual hallucinations in people with Lewy body dementia.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: 85 Years

Must have:

  • Diagnosis of Lewy body dementia or Parkinson's disease dementia, based on DSM-5 diagnostic criteria
  • Presence of frequent visual hallucinations
  • Mini-Mental State Examination score of 18

Must NOT have:

  • Current diagnosis of significant psychotic disorders, including but not limited to schizophrenia or bipolar disorder
  • Psychotic symptoms are secondary to or better accounted for by another medical condition, psychiatric disorder, or substance abuse
  • Current, serious, and/or unstable cardiovascular, respiratory, thyroid, gastrointestinal, renal, hematologic, or other medical disorder

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Who Is the General Study Contact?

For more information about this clinical trial, please contact Axovant Clinical Trials at 919-425-0709 or visit www.lbda.org/nelotanserin-VH.

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Axovant Sciences Ltd.

Source: ClinicalTrials.gov ID: NCT02640729

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health